The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|11|3|179-186

ISSN： 1570-162X

Source： Current HIV Research, Vol.11, Iss.3, 2013-04, pp. : 179-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The DUET trials: etravirine in the management of treatment-experienced HIV-1-infected patients

By Mills Anthony M  

HIV Therapy, Vol. 4, Iss. 3, 2010-05 ,pp. : 265-280

Future Medicine

Access to resources Recommend Favorite

Long-Term Gender-Based Outcomes for Atazanavir/Ritonavir (ATV/r)- Containing Regimens in Treatment-Experienced Patients with HIV

By  

Current HIV Research, Vol. 11, Iss. 4, 2013-06 ,pp. : 333-341

Bentham Science Publishers

Access to resources Recommend Favorite

Naringin Ameliorates HIV-1 Nucleoside Reverse Transcriptase Inhibitors- Induced Mitochondrial Toxicity

By  

Current HIV Research, Vol. 14, Iss. 6, 2016-12 ,pp. : 506-516

Bentham Science Publishers

Access to resources Recommend Favorite

Initiation of therapy with a subcutaneously administered antiretroviral in treatment-experienced HIV-infected patients: understanding physician and patient perspectives

By Horne Rob   Cooper Vanessa   Fisher Martin  

AIDS Care, Vol. 20, Iss. 9, 2008-10 ,pp. : 1029-1038

Routledge Ltd

Access to resources Recommend Favorite

Quadruple Nucleos(t)ide Reverse Transcriptase Inhibitors-Only Regimen of Tenofovir Plus Zidovudine/Lamivudine/Abacavir in Heavily Pre-Treated HIV-1 Infected Patients: Salvage Therapy or Backbone Only?

By  

Current HIV Research, Vol. 7, Iss. 3, 2009-05 ,pp. : 320-326

Bentham Science Publishers

Access to resources Recommend Favorite